Biography
Dr. Kim is a health services researcher specializing in the evaluation of health policies related to prescription drug access. Her research focuses on examining the relationships between drug insurance coverage, prescription affordability, quality of utilization, and patient health outcomes. She has led and contributed to numerous research projects evaluating state and federal-level policies that directly impact drug affordability.
Dr. Kim possesses extensive expertise in analyzing large-scale healthcare data, including Medicare and Medicaid enrollment and claims databases, as well as national-level health surveys. Currently, she is a Co-investigator on an NIH R01 project (PI: Rebecca Myerson) evaluating the impact of the Inflation Reduction Act’s out-of-pocket cost cap for insulins, where Dr. Kim leads the comprehensive data management and analysis, ensuring the successful execution of the study.
Prior to this, Dr. Kim served as the lead scientist evaluating the Wisconsin SeniorCare program, a prescription drug assistance program for near-poor older adults who do not qualify for Medicaid benefits. She has also evaluated Wisconsin’s expanded Medicaid drug benefits for childless adults and their impact on drug affordability and medication adherence.
She holds a PhD in Social and Administrative Sciences in Pharmacy from the University of Wisconsin-Madison School of Pharmacy. Prior to her doctoral studies, she practiced as a registered pharmacist in South Korea and worked as a Health Economics and Outcomes Research (HEOR) associate at Bayer Korea.